Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models.
Dai H, Zhu C, Huai Q, Xu W, Zhu J, Zhang X, Zhang X, Sun B, Xu H, Zheng M, Li X, Wang H.
Dai H, et al. Among authors: xu w, xu h.
J Hepatol. 2024 Feb 8:S0168-8278(24)00113-2. doi: 10.1016/j.jhep.2024.01.034. Online ahead of print.
J Hepatol. 2024.
PMID: 38340812